These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 5761734)

  • 1. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
    Frohlich ED; Tarazi RC; Dustan HP
    Arch Intern Med; 1969 Jan; 123(1):1-7. PubMed ID: 5761734
    [No Abstract]   [Full Text] [Related]  

  • 2. Increases beta-receptor responsiveness; central or peripheral?
    Davis JN
    Arch Intern Med; 1969 Jan; 123(1):101-2. PubMed ID: 5761732
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperdynamic beta-adrenergic circulatory state. An overview.
    Frohlich ED; Dustan HP; Tarazi RC
    Arch Intern Med; 1970 Dec; 126(6):1068-9. PubMed ID: 5483599
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 7. [ Sensitivity of alpha- and betareceptors in patients with hypertension].
    Komor K; Décsy J; Herpai Z; Krassói A; Vass I; Simonyi J
    Z Kreislaufforsch; 1970 Sep; 59(9):805-13. PubMed ID: 5460456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of xantinol-nicotinate on heart and blood circulation].
    Lang E; Köhler JA
    Arzneimittelforschung; 1969 Nov; 19(11):1870-3. PubMed ID: 5395658
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.
    Hansson L; Zweifler AJ; Julius S; Hunyor SN
    Acta Med Scand; 1974; 196(1-2):27-34. PubMed ID: 4370849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
    Dück KD; Knappe J; Strube G
    Z Gesamte Inn Med; 1973 Aug; 28(16):Suppl:248-51. PubMed ID: 4767603
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta adrenergic blockade on the cardiovascular system in the state of sympathicotonia in children].
    Baszczyński J
    Pediatr Pol; 1968; 44(1):47-52. PubMed ID: 5728842
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic and phonocardiographic changes after propranolol in sympathotonia].
    Aigner A; Baumgartl P; Bolzano K; Raas E
    Dtsch Med Wochenschr; 1970 Dec; 95(52):2604-7. PubMed ID: 5487514
    [No Abstract]   [Full Text] [Related]  

  • 15. Ureteral peristalsia and the autonomic nervous system.
    Kaplan N; Elkin M; Sharkey J
    Invest Urol; 1968 Mar; 5(5):468-82. PubMed ID: 5651066
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 17. The unimportance of autonomic control of the heart in mediating the response of cardiac output to a fall of peripheral resistance.
    Lowe RD; Robinson BF
    J Physiol; 1967 Apr; 189(2):68P-69P. PubMed ID: 6034132
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of propranolol hydrochloride (inderal).
    JAMA; 1973 Sep; 225(11):1380-4. PubMed ID: 4146773
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of Drotaverin on the blood circulation of healthy persons with and without isoproterenol stimulation].
    Baumgartl P; Knapp E; Aigner A; Raas E
    Wien Z Inn Med; 1972; 53(10):539-41. PubMed ID: 4405522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.